Neurology Live, August 31, 2023
The SYNTap biomarker test (Amprion), first in its class qualitative laboratory developed test, is the only seed amplification assay that is available for helping to diagnosis synucleinopathies including Parkinson disease (PD), Lewy Body dementia (DLB), and Alzheimer disease (AD). Recently, Amprion was contracted by the National Institutes of Health (NIH) Intramural Research Program’s Center for Alzheimer’s and Related Dementias (CARD) to investigate the levels of misfolded alpha-synuclein proteins in patients with AD using data gathered from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)...READ MORE
